Safety Shot (NASDAQ:SHOT) Upgraded to “Hold” at Wall Street Zen

Safety Shot (NASDAQ:SHOT) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Saturday.

Safety Shot Stock Performance

SHOT stock opened at $0.65 on Friday. The firm has a 50 day moving average of $0.53 and a 200-day moving average of $0.48. Safety Shot has a 12 month low of $0.23 and a 12 month high of $1.77.

Safety Shot (NASDAQ:SHOT) last released its quarterly earnings data on Thursday, August 14th. The company reported ($0.03) EPS for the quarter. The firm had revenue of $0.45 million for the quarter.

Institutional Investors Weigh In On Safety Shot

Several hedge funds have recently bought and sold shares of SHOT. XTX Topco Ltd bought a new stake in Safety Shot during the first quarter valued at approximately $59,000. Jane Street Group LLC raised its stake in shares of Safety Shot by 397.7% during the fourth quarter. Jane Street Group LLC now owns 102,267 shares of the company’s stock worth $74,000 after acquiring an additional 81,720 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Safety Shot by 13.3% during the fourth quarter. Geode Capital Management LLC now owns 491,743 shares of the company’s stock worth $354,000 after acquiring an additional 57,876 shares in the last quarter. Finally, Tyche Wealth Partners LLC raised its stake in shares of Safety Shot by 142.9% during the second quarter. Tyche Wealth Partners LLC now owns 85,000 shares of the company’s stock worth $28,000 after acquiring an additional 50,000 shares in the last quarter. 12.55% of the stock is currently owned by institutional investors.

Safety Shot Company Profile

Safety Shot, Inc, a wellness and functional beverage company, researches and develops over-the-counter products and intellectual property. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It also develops Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; and NoStingz, a jellyfish sting prevention sunscreen.